FDA Inspection 1095950 — Curium US LLC
The FDA completed an inspection of Curium US LLC on Jun 14, 2019 in Noblesville, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 14, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Noblesville, IN (United States)